Questions and answers 

100 Questions and Answers About MASH

 

Understanding MASH

  1. What is MASH? It's the inflammatory form of fatty liver disease—liver fat plus inflammation and liver cell injury, driven by metabolic dysfunction.

  2. What does MASH stand for? Metabolic dysfunction–Associated Steatohepatitis.

  3. When did the term MASH come into use? It was adopted in June 2023 through a multi-society consensus, replacing "NASH."

  4. Why was NASH renamed MASH? To reduce stigma, drop the imprecise word "nonalcoholic," and highlight the metabolic root of the disease.

  5. What's the difference between MASLD and MASH? MASLD is the broad umbrella (fatty liver with metabolic risk factors); MASH is the more advanced, inflamed subtype within it.

  6. Is MASH worse than simple fatty liver? Yes—simple steatosis is just fat storage, while MASH adds inflammation and cell damage that can progress to scarring.

  7. What does "steatohepatitis" mean? "Steato" (fat) + "hepat" (liver) + "itis" (inflammation): fatty liver with inflammation.

  8. Is MASH a type of viral hepatitis? No—it causes liver inflammation but is metabolic in origin, unlike hepatitis B or C.

  9. How is MASH different from alcohol-related liver disease? They can look alike under a microscope, but MASH is driven by metabolic factors, not heavy alcohol use.

  10. What is MetALD? A category for people with MASH-type disease who also drink moderate amounts of alcohol.

What Happens in the Liver

  1. What actually happens to the liver in MASH? Fat accumulates in liver cells, then inflammation and cell injury develop, which can trigger scarring.

  2. What is "ballooning" in MASH? A form of liver cell swelling and injury that pathologists look for as a hallmark of MASH.

  3. What is steatosis? The buildup of fat (mainly triglycerides) inside liver cells—the starting point of the disease.

  4. What is fibrosis? Scar tissue the liver forms in response to ongoing injury and inflammation.

  5. What is the "multiple hits" idea? A model describing how genetics, diet, gut bacteria, and metabolic stress combine to drive MASH forward.

  6. Does the gut play a role in MASH? Yes—the gut microbiome is increasingly recognized as influencing liver inflammation.

  7. Why does insulin resistance matter? It promotes fat delivery to and storage in the liver and fuels inflammation.

  8. What is oxidative stress in MASH? Cellular damage from unstable molecules that contributes to liver cell injury.

  9. Does everyone with fatty liver develop MASH? No—many people stay at simple steatosis and never progress.

  10. Can the liver heal from MASH? Early inflammation and even some fibrosis can improve with sustained metabolic health.

Causes & Risk Factors

  1. What causes MASH? A mix of excess liver fat, insulin resistance, inflammation, genetics, and metabolic stress.

  2. Who is most at risk? People with obesity, type 2 diabetes, or metabolic syndrome.

  3. Is MASH linked to diabetes? Strongly—type 2 diabetes raises risk and tends to speed progression.

  4. Does obesity cause MASH? Abdominal (visceral) fat is a major driver, though not everyone with obesity develops it.

  5. Can lean people get MASH? Yes—"lean MASH" occurs, usually with underlying metabolic dysfunction.

  6. Is MASH genetic? Genetics contribute; variants like PNPLA3, TM6SF2, and HSD17B13 influence risk and progression.

  7. Which gene is most associated with MASH? PNPLA3 is the most studied, linked to higher risk in several populations.

  8. Does diet contribute? Yes—diets high in added sugar, refined carbs, and saturated fat raise risk.

  9. Is fructose harmful to the liver? Excess fructose, especially from sugary drinks, is linked to liver fat buildup.

  10. Does inactivity increase risk? Yes—a sedentary lifestyle promotes fat accumulation and insulin resistance.

  11. How is MASH connected to metabolic syndrome? Many consider it the liver expression of metabolic syndrome.

  12. Can abnormal cholesterol contribute? High triglycerides and low HDL are associated cardiometabolic factors.

  13. Does high blood pressure play a role? It's one of the clustered metabolic risk factors.

  14. Is sleep apnea connected? Yes—obstructive sleep apnea is associated with higher risk.

  15. Is PCOS a risk factor? Yes—polycystic ovary syndrome is linked to increased risk.

  16. Can hypothyroidism raise risk? Underactive thyroid and some other hormone conditions are associated with it.

  17. Can medications contribute? Certain drugs can worsen liver fat, though most MASH is metabolic.

Symptoms & Warning Signs

  1. What are the symptoms of MASH? Often none early on—it can be silent for years.

  2. Why is MASH called a "silent" disease? Because many people have no symptoms until it's advanced.

  3. Can MASH cause fatigue? Yes—tiredness is a common nonspecific symptom.

  4. Does MASH cause pain? Some feel vague discomfort or fullness in the upper right abdomen.

  5. Can you have MASH and feel fine? Yes—many people feel completely normal despite real liver changes.

  6. What are signs of advanced disease? Jaundice, leg or abdominal swelling, confusion, or easy bruising can signal advanced liver disease.

  7. Can MASH cause itching? Advanced liver disease can sometimes cause itching.

  8. Are symptoms a reliable way to detect MASH? No—which is exactly why testing matters.

Diagnosis & Testing

  1. How is MASH diagnosed? With a combination of blood tests, imaging, and sometimes a liver biopsy.

  2. What blood tests are involved? Liver enzymes (ALT, AST) plus fibrosis scores like FIB-4.

  3. Can liver enzymes be normal in MASH? Yes—normal enzymes don't rule out significant disease.

  4. What is a FIB-4 score? A simple calculation using age and routine blood tests to estimate fibrosis risk.

  5. What is the ELF test? The Enhanced Liver Fibrosis blood panel that estimates scarring.

  6. What imaging is used? Ultrasound, FibroScan, and MRI-based methods.

  7. What is a FibroScan? A noninvasive device measuring liver stiffness (fibrosis) and fat.

  8. What is MRI-PDFF? An MRI method that precisely measures the percentage of liver fat.

  9. What is MR elastography? A highly accurate MRI technique to assess liver scarring.

  10. Is a liver biopsy always needed? Not always, but it remains the most definitive way to confirm MASH and stage fibrosis.

  11. What does a biopsy reveal? Fat, inflammation, cell injury (ballooning), and the degree of scarring.

  12. Can MASH be diagnosed without a biopsy? Increasingly yes, using noninvasive tests, though biopsy is still the gold standard.

  13. What is fibrosis staging? A scale from F0 (no scarring) to F4 (cirrhosis).

  14. Why does fibrosis stage matter so much? It's the single strongest predictor of long-term outcomes.

  15. What is the MASH "activity" versus fibrosis distinction? Activity reflects current inflammation/injury; fibrosis reflects accumulated scarring—both are assessed.

Progression & Complications

  1. Does MASH always get worse? No—progression varies, and some people stay stable for years.

  2. Can MASH lead to cirrhosis? Yes—advanced MASH can progress to cirrhosis.

  3. What is cirrhosis? Advanced, largely permanent scarring that impairs liver function.

  4. Is cirrhosis reversible? Generally no, though progression can sometimes be slowed or halted.

  5. Can MASH cause liver cancer? Yes—it can lead to hepatocellular carcinoma (HCC).

  6. Can MASH cause liver cancer without cirrhosis? Uncommonly, yes—a notable feature of this disease.

  7. How fast does MASH progress? Usually slowly, over years to decades, but rates vary widely.

  8. Can MASH lead to liver failure? In advanced stages, yes.

  9. Is MASH a common reason for liver transplant? Yes—it's a rapidly growing indication for transplantation.

  10. What are complications of MASH cirrhosis? Fluid buildup (ascites), internal (variceal) bleeding, and confusion (encephalopathy).

  11. Does everyone with MASH need a transplant? No—most people never reach that stage.

Whole-Body Impact

  1. Is MASH only a liver problem? No—it reflects and affects whole-body metabolic health.

  2. What's the leading cause of death in people with MASH? Cardiovascular disease, not liver disease.

  3. Does MASH raise heart disease risk? Yes—significantly.

  4. Is MASH linked to kidney disease? Yes—it's associated with chronic kidney disease.

  5. Can MASH raise cancer risk beyond the liver? It's associated with certain non-liver cancers.

  6. How do MASH and diabetes interact? They tend to worsen each other.

  7. Does MASH affect life expectancy? Advanced disease is associated with higher mortality risk.

Lifestyle Management

  1. What's the foundation of MASH treatment? Lifestyle change—especially weight loss and metabolic improvement.

  2. How much weight loss helps? About 5% reduces liver fat; 7–10% can improve inflammation and even some scarring.

  3. What's the best-supported diet? The Mediterranean diet has the strongest evidence.

  4. Should I cut back on sugar? Reducing added sugars, especially sugary drinks, is widely recommended.

  5. Does exercise help even without weight loss? Yes—both aerobic and resistance training reduce liver fat independently of weight change.

  6. How much exercise is recommended? Generally at least 150 minutes of moderate activity weekly, tailored to you.

  7. Should I avoid alcohol with MASH? Limiting or avoiding alcohol is generally advised, since it can compound injury.

  8. Is coffee helpful? Studies associate coffee with lower fibrosis risk, though it's not a treatment.

  9. Is crash dieting a good idea? No—gradual, sustained weight loss is preferred over rapid crash diets.

  10. Can lifestyle change reverse MASH? In many cases, sustained changes can improve or reverse earlier disease.

  11. Do I need to manage other conditions too? Yes—controlling diabetes, cholesterol, and blood pressure is essential.

  12. Does quitting smoking help? Yes—smoking worsens both cardiovascular and liver risk.

Medications & Treatments

  1. Is there an approved drug for MASH? Yes—resmetirom (Rezdiffra) was FDA-approved in March 2024.

  2. What is resmetirom? A thyroid hormone receptor-beta agonist that targets liver fat and scarring.

  3. Who is resmetirom intended for? Adults with MASH and moderate to advanced fibrosis, alongside lifestyle change.

  4. Are GLP-1 drugs used for MASH? Drugs like semaglutide show promise and are under active study.

  5. Is vitamin E used? In select non-diabetic patients under specialist guidance.

  6. Are statins safe with MASH? Yes—they're generally safe and important for heart health.

  7. Can bariatric surgery help? Yes—it can significantly improve MASH in people with severe obesity.

  8. Is there a cure for MASH? Not a single cure—treatment focuses on halting or reversing progression.

  9. Are more treatments coming? Yes—many drugs targeting fat, inflammation, and fibrosis are in clinical trials.

  10. What's the single most important thing to know about MASH? Early detection and sustained metabolic health offer the best chance to prevent serious liver damage.